Enhancing Cardiovascular Risk Prediction with a Simplified Carotid IMT Protocol: Evidence from the IMPROVE Study
<b>Background/Objectives</b>: Carotid intima-media thickness (CIMT) has long been used as an index of subclinical atherosclerosis, but its role as a risk modifier in cardiovascular (CV) risk optimization has recently been questioned due to methodological problems, such as lack of protocol standardization and scanning difficulties. In this multicentre, longitudinal, and observational study, we tested the predictive ability of two new CIMT variables detectable with a simplified, quick, and easy-to-standardize protocol. <b>Methods</b>: CIMT was measured in 3165 subjects from six centers, in five European countries, belonging to the IMPROVE study. The two variables tested were the average of two maximal CIMT measures taken, from a single angle, in the right and left common carotids (1CC-IMT<sub>mean-of-2-max</sub>) or bifurcations (BIF-IMT<sub>mean-of-2-max</sub>). The ability to predict CV events, on top of the SCORE2/SCORE2-OP risk algorithm, was quantified by the time-dependent increase in the receiver operating characteristic (ROC) area under the curve (AUC). <b>Results</b>: During a median follow-up of 7.1 years, 367 cardio-, cerebro-, and peripheral-vascular events were registered. Both CIMT variables tested were associated with CV risk, but 1CC-IMT<sub>mean-of-2-max</sub> was also able to significantly increase the ROC AUC over the risk score (+0.017, <i>p</i> = 0.014). The result was stable after running several sensitivity analyses. <b>Conclusions</b>: 1CC-IMT<sub>mean-of-2-max</sub> is able to significantly improve the predictive capacity of SCORE2/SCORE2-OP. Being based on a simple and easily standardized measurement protocol, this new variable is a promising candidate for application in mass screening and risk assessment in primary prevention.
Authors
- Matteo Pirro (ORCID: https://orcid.org/0000-0002-5527-4821)
- Roberta Baetta (ORCID: https://orcid.org/0000-0001-7190-4638)
- Bruna Gigante (ORCID: https://orcid.org/0000-0003-4508-7990)
- Anna Maria Malagoni (ORCID: https://orcid.org/0000-0002-3362-4691)
- Philippe Giral (ORCID: https://orcid.org/0000-0002-1863-1711)
- B. Frigerio
- Per Eriksson (ORCID: https://orcid.org/0000-0002-5635-2692)
- Daniela Sansaro (ORCID: https://orcid.org/0000-0001-8403-4520)
- Nicolò Capra (ORCID: https://orcid.org/0000-0003-1974-2015)
- A. Ravani (ORCID: https://orcid.org/0000-0003-4894-7685)
- Fabrizio Veglia (ORCID: https://orcid.org/0000-0002-9378-8874)
- Mauro Amato (ORCID: https://orcid.org/0000-0002-0118-5719)
- Antonio Gallo (ORCID: https://orcid.org/0000-0002-8887-994X)
- Rona J. Strawbridge (ORCID: https://orcid.org/0000-0001-8506-3585)
- Damiano Baldassarre (ORCID: https://orcid.org/0000-0002-2766-8882)
- Daniela Coggi (ORCID: https://orcid.org/0000-0003-3857-298X)
- Douwe J. Mulder (ORCID: https://orcid.org/0000-0003-3715-6474)
- Kai Savonen (ORCID: https://orcid.org/0000-0002-6871-8153)
- Elena Tremoli (ORCID: https://orcid.org/0000-0003-3426-6424)
Institutions
- University Medical Center Groningen (NL)
- Karolinska University Hospital (SE)
- Inserm (FR)
- University of Groningen (NL)
- University of Eastern Finland (FI)
- University of Milan (IT)
- University of Perugia (IT)
- Karolinska Institutet (SE)
- Sorbonne Université (FR)
- Centro Cardiologico Monzino (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Maria Cecilia Hospital (IT)
- Pitié-Salpêtrière Hospital (FR)
- Health Data Research UK (GB)
- Unité de recherche sur les maladies cardiovasculaires et métaboliques (FR)
- University of Glasgow (GB)
Publication Details
- Journal
- Biomedicines
- Published
- 2025-02-26
- DOI
- https://doi.org/10.3390/biomedicines13030584
- Citations
- 3
- Primary Topic
- Cardiovascular Health and Disease Prevention
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- European Commission
- Ministero della Salute